Showing results (21-30 of 142) with videos related to
Sort By:
Pageof 15
Thrombosis Research|August 19, 2007
Plasma levels of P-selectin are determined by platelet turn-over and the P-selectin Thr715Pro polymorphismSimon Panzer, Sergio Rosales, Heinz Gisslinger, et al.Haematologica|November 11, 2003
Circulating hematopoietic progenitor cells predict survival in patients with myelofibrosis with myeloid metaplasiaVerena Sagaster, Eva Jäger, Ansgar Weltermann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Low p27Kip1 expression is an independent adverse prognostic factor in patients with multiple myelomaMartin Filipits, Gudrun Pohl, Thomas Stranzl, et al.Blood Cancer Journal|February 11, 2018
The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussionTiziano Barbui, Jürgen Thiele, Heinz Gisslinger, et al.Journal of Cardiac Surgery|July 16, 2020
Acute oxygenator occlusion in two cases of polycythemia vera: Bailout strategiesPhilipp Kaiser, Andreas Zuckermann, Johann Horvat, et al.Blood|January 15, 2013
Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trialHeinz Gisslinger, Mirjana Gotic, Jerzy Holowiecki, et al.European Journal of Haematology|April 3, 2016
Influence of platelet and white blood cell counts on major thrombosis - analysis from a patient registry in essential thrombocythemiaVeronika Buxhofer-Ausch, Michael Steurer, Siegfried Sormann, et al.Haematologica|March 8, 2005
Mutation of the prothrombin gene and thrombotic events in patients with polycythemia vera or essential thrombocythemia: a cohort studyHeinz Gisslinger, Marcus Müllner, Ingrid Pabinger, et al.Haematologica|October 13, 2005
Pegylated interferon for the treatment of high risk essential thrombocythemia: results of a phase II studyChristian Langer, Eva Lengfelder, Jürgen Thiele, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2005
Vascular and neoplastic risk in a large cohort of patients with polycythemia veraRoberto Marchioli, Guido Finazzi, Raffaele Landolfi, et al.Pageof 15